These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24965454)

  • 1. Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy.
    Murin CD; Julien JP; Sok D; Stanfield RL; Khayat R; Cupo A; Moore JP; Burton DR; Wilson IA; Ward AB
    J Virol; 2014 Sep; 88(17):10177-88. PubMed ID: 24965454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
    Kong L; Lee JH; Doores KJ; Murin CD; Julien JP; McBride R; Liu Y; Marozsan A; Cupo A; Klasse PJ; Hoffenberg S; Caulfield M; King CR; Hua Y; Le KM; Khayat R; Deller MC; Clayton T; Tien H; Feizi T; Sanders RW; Paulson JC; Moore JP; Stanfield RL; Burton DR; Ward AB; Wilson IA
    Nat Struct Mol Biol; 2013 Jul; 20(7):796-803. PubMed ID: 23708606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-course, negative-stain electron microscopy-based analysis for investigating protein-protein interactions at the single-molecule level.
    Nogal B; Bowman CA; Ward AB
    J Biol Chem; 2017 Nov; 292(47):19400-19410. PubMed ID: 28972148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy.
    Lee JH; de Val N; Lyumkis D; Ward AB
    Structure; 2015 Oct; 23(10):1943-1951. PubMed ID: 26388028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
    Sanders RW; Derking R; Cupo A; Julien JP; Yasmeen A; de Val N; Kim HJ; Blattner C; de la Peña AT; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; van Gils MJ; King CR; Wilson IA; Ward AB; Klasse PJ; Moore JP
    PLoS Pathog; 2013 Sep; 9(9):e1003618. PubMed ID: 24068931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
    Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
    J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.
    Kong L; Torrents de la Peña A; Deller MC; Garces F; Sliepen K; Hua Y; Stanfield RL; Sanders RW; Wilson IA
    Acta Crystallogr D Biol Crystallogr; 2015 Oct; 71(Pt 10):2099-108. PubMed ID: 26457433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer.
    Gristick HB; Wang H; Bjorkman PJ
    Acta Crystallogr D Struct Biol; 2017 Oct; 73(Pt 10):822-828. PubMed ID: 28994411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to the HIV-1 envelope high mannose patch.
    Daniels CN; Saunders KO
    Adv Immunol; 2019; 143():11-73. PubMed ID: 31607367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer.
    Sarkar A; Bale S; Behrens AJ; Kumar S; Sharma SK; de Val N; Pallesen J; Irimia A; Diwanji DC; Stanfield RL; Ward AB; Crispin M; Wyatt RT; Wilson IA
    Nat Commun; 2018 May; 9(1):1956. PubMed ID: 29769533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.
    Pejchal R; Doores KJ; Walker LM; Khayat R; Huang PS; Wang SK; Stanfield RL; Julien JP; Ramos A; Crispin M; Depetris R; Katpally U; Marozsan A; Cupo A; Maloveste S; Liu Y; McBride R; Ito Y; Sanders RW; Ogohara C; Paulson JC; Feizi T; Scanlan CN; Wong CH; Moore JP; Olson WC; Ward AB; Poignard P; Schief WR; Burton DR; Wilson IA
    Science; 2011 Nov; 334(6059):1097-103. PubMed ID: 21998254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
    Zhang MY; Yuan T; Li J; Rosa Borges A; Watkins JD; Guenaga J; Yang Z; Wang Y; Wilson R; Li Y; Polonis VR; Pincus SH; Ruprecht RM; Dimitrov DS
    PLoS One; 2012; 7(9):e44241. PubMed ID: 22970187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.
    Lee JH; Andrabi R; Su CY; Yasmeen A; Julien JP; Kong L; Wu NC; McBride R; Sok D; Pauthner M; Cottrell CA; Nieusma T; Blattner C; Paulson JC; Klasse PJ; Wilson IA; Burton DR; Ward AB
    Immunity; 2017 Apr; 46(4):690-702. PubMed ID: 28423342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies.
    Yuan M; Cottrell CA; Ozorowski G; van Gils MJ; Kumar S; Wu NC; Sarkar A; Torres JL; de Val N; Copps J; Moore JP; Sanders RW; Ward AB; Wilson IA
    Cell Host Microbe; 2019 Jun; 25(6):873-883.e5. PubMed ID: 31194940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.
    Doores KJ; Fulton Z; Huber M; Wilson IA; Burton DR
    J Virol; 2010 Oct; 84(20):10690-9. PubMed ID: 20702629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
    Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
    J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
    Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
    J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.
    Agrawal-Gamse C; Luallen RJ; Liu B; Fu H; Lee FH; Geng Y; Doms RW
    J Virol; 2011 Jan; 85(1):470-80. PubMed ID: 20962094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.